111 Inc
NASDAQ:YI

  • LAST PRICE
    1.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.9600/ 200
  • Ask / Lots
    1.3200/ 10
  • Open / Previous Close
    0.0000 / 1.0000
  • Day Range
    ---
  • 52 Week Range
    0.9701
    3.3600
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

  • Apr 2, 2024

  • Mar 28, 2024

  • Mar 21, 2024

      Show headlines and story abstract

    • 4:47AM ET on Thursday Mar 21, 2024 by PR Newswire
      Companies Mentioned: YI

      111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2023.

    • 4:47AM ET on Thursday Mar 21, 2024 by Dow Jones
      Companies Mentioned: YI
      provided by investing activities (118,198) 59,830 8,427 (47,173) 151,743 21,372 Net cash provided by financing activities 21,818 1,748 245 22,735 205,978 29,011 Effect of exchange rate changes on cash and cash equivalents, and restricted cash (9,274) (7,234) (1,019) 3,709 (3,720) (524) --------- --------- -------- -------- --------- --------- Net decrease in cash and cash equivalents, and restricted cash (42,445) (142,670) (20,096) (43,881) (93,243) (13,134) --------- --------- -------- -------- --------- --------- Cash and cash equivalents, and restricted cash at the beginning of the period 759,236 766,218 107,920 760,672 716,791 100,958 --------- --------- -------- -------- --------- --------- Cash and cash equivalents, and restricted cash at the end of the period 716,791 623,548 87,824 716,791 623,548 87,824 ========= ========= ======== ======== ========= ========= 111, Inc. Unaudited Reconciliation of GAAP and Non-GAAP Results (In thousands, except for share and per share data) For the three months ended December 31, For the year ended December 31, 2022 2023 2022 2023 --------- ------------------- --------- -------------------- RMB RMB US$ RMB RMB US$ --------- --------- -------- --------- --------- --------- Loss from operations (108,427) (206,538) (29,089) (371,001) (350,097) (49,311) Add: Share-based compensation expenses 68,692 151,352 21,317 157,384 226,170 31,855 --------- --------- -------- --------- --------- --------- Non-GAAP loss from operations (39,735) (55,186) (7,772) (213,617) (123,927) (17,456) ========= ========= ======== ========= ========= ========= Net Loss (104,076) (205,221) (28,904) (376,069) (353,433) (49,781) Add: Share-based compensation expenses, net of tax 68,692 151,352 21,317 157,384 226,170 31,855 Non-GAAP net Loss (35,384) (53,869) (7,587) (218,685) (127,263) (17,926) Net Loss attributable to ordinary shareholders (114,431) (210,366) (29,629) (416,878) (392,693) (55,311) Add: Share-based compensation expenses, net of tax 68,692 151,352 21,317 157,384 226,170 31,855 --------- --------- -------- --------- --------- --------- Non-GAAP net Loss attributable to ordinary shareholders (45,739) (59,014) (8,312) (259,494) (166,523) (23,456) ========= ========= ======== ========= ========= ========= Loss per ADS(6) : Basic and diluted (1.38) (2.48) (0.34) (5.00) (4.66) (0.66) Add: Share-based compensation expenses per ADS(6) , net of tax 0.82 1.78 0.26 1.88 2.68 0.38 --------- --------- -------- --------- --------- --------- Non-GAAP Loss per ADS(6) (0.56) (0.70) (0.08) (3.12) (1.98) (0.28) ========= ========= ======== ========= ========= ========= (6) Every one ADSs represent two Class A ordinary shares.

Peers Headlines